The Asia Pacific Vascular Graft Market size is predicted to grow at a robust CAGR between 2021 to 2026. The Asia Pacific Vascular Graft Market is developing at a rapid pace.
The APAC vascular graft market is expected to be driven by the rising prevalence of diabetes, the high number of chronic kidney diseases, the increase in the incidence of end-stage renal disease, and necessitating hemodialysis across the region. Furthermore, the increased prevalence of thoracic and abdominal aortic aneurysms and peripheral aortic illness among the growing elderly population is expected to boost the market growth.
On the other hand, other factors such as high junk food intake, tobacco consumption, substance abuse, and alcohol addiction influence the vascular graft market. Abdominal Aortic Aneurysm (AAA) is a severe medical disorder in which the aorta swells and causes serious health problems. People over the age of 60 are at a higher risk. As a result, segment expansion growth is aided by the growing senior population and favorable reimbursement policies.
In addition, with the emergence of minimally invasive surgeries that result in a shorter hospital stay and faster recovery, the demand for abdominal aortic aneurysm repair is expected to rise in the future. Furthermore, the increased burden of cardiovascular and renal ailments and sophisticated surgical techniques in hospitals will move the segment forward. Moreover, the rising patient pool and the launch of novel surgical methods will boost market revenue.
Infections linked to vascular grafts and a scarcity of competent doctors in developing nations could limit market expansion. The significant restriction is the high expense of therapy and complications associated with prosthetic grafts.
This research report on the APAC vascular graft market has been segmented and sub-segmented into the following categories:
By Raw Material:
The Asia Pacific is the fastest-growing region due to an increase in chronic diseases, growing medical tourism activities, and increased public and private healthcare expenditure. Emerging markets such as Singapore, China, Japan, and Australia create the considerable potential for competitors in the APAC vascular grafts market. Due to liberal regulatory rules and an increase in the burden of aneurysms, the market is likely to rise significantly in the following years.
The market for vascular grafts in China is expected to increase at 7.2% over the projected period, owing to improved healthcare infrastructure and rising rates of cardiovascular disorders (CVDs) and diabetes. Furthermore, because of the rapid epidemiological transformation that has resulted in many premature deaths, demand for minimally invasive grafting techniques is likely to increase. Moreover, the demand for vascular grafts has increased in the country due to the development of creative and revolutionary vascular bypass procedures.
According to the Asia Pacific Society of Nephrology survey, chronic kidney disease affects roughly 17% Indians. In India, approximately 40% of people with diabetes experience signs of end-stage renal disease. As a result of the rising prevalence of diabetes and the high number of chronic kidney diseases, the incidence of end-stage renal disease would rise, necessitating hemodialysis.
KEY MARKET PLAYERS:
Endologix Inc., LeMaitre Vascular, Inc., MAQUET Holding B.V.B. Braun Melsungen AG, & Co. KG, Medtronic plc, C. R. Bard, Inc., Cardinal Health Inc., Cook Medical Inc., Terumo Corporation, and W. L. Gore & Associates, Inc. are the key players in the Asia Pacific Vascular Graft Market.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1.2 Peripheral Vascular Graft
5.1.3 Endovascular Aneurysm Repair Stent Grafts
5.1.4 Hemodialysis Access Graft
5.1.5 Y-o-Y Growth Analysis, By Product
5.1.6 Market Attractiveness Analysis, By Product
5.1.7 Market Share Analysis, By Product
5.2 Raw Material
5.2.4 Polyurethane (PU)
5.2.5 Polytetrafluoroethylene (PTFE)
5.2.6 Y-o-Y Growth Analysis, By Raw Material
5.2.7 Market Attractiveness Analysis, By Raw Material
5.2.8 Market Share Analysis, By Raw Material
5.3 End User
5.3.2 Ambulatory Surgical Centers
5.3.4 Y-o-Y Growth Analysis, By End User
5.3.5 Market Attractiveness Analysis, By End User
5.3.6 Market Share Analysis, By End User
5.4.2 Coronary Artery Disease
5.4.4 Vascular Occlusion
5.4.5 Renal Failure
5.4.7 Y-o-Y Growth Analysis, By Applications
5.4.8 Market Attractiveness Analysis, By Applications
5.4.9 Market Share Analysis, By Applications
6. Geographical Analysis
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
220.127.116.11 By Geographical Area
18.104.22.168 By Product
22.214.171.124 By Raw Material
126.96.36.199 By End User
188.8.131.52 By Application
6.1.4 Market Attractiveness Analysis
184.108.40.206 By Geographical Area
220.127.116.11 By Product
18.104.22.168 By Raw Material
22.214.171.124 By End User
126.96.36.199 By Application
6.1.5 Market Share Analysis
188.8.131.52 By Geographical Area
184.108.40.206 By Product
220.127.116.11 By Raw Material
18.104.22.168 By End User
22.214.171.124 By Application
6.5 South Korea
7. Strategic Analysis
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Cardinal Health Inc.
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 B. Braun Melsungen AG
8.3 Cook Medical Inc.
8.4 MAQUET Holding B.V.& Co.
8.5 Medtronic plc
8.6 Terumo Corporation
8.7 W. L. Gore & Associates, Inc.
8.8 LeMaitre Vascular
8.9 Endologix Inc.
8.10 C. R. Bard, Inc.
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
a) List of Tables
b) List of Figures